PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS

  • Reyes Alirio Torres Chair of Parasitology. School of Medicine. University of Zulia. Dermatology and Medical Mycology Unit. University Hospital of Maracaibo.
  • Nieves Vargas de Caminos Chair of Tropical Medicine. School of Medicine. University of Zulia. Dermatology and Medical Mycology Unit. University Hospital of Maracaibo.
Keywords: Leishmaniasis, treatment, glucamine, lidocaine

Abstract

In order to evaluate the therapeutic effect of perilesional infiltration of a mixture of Glucantime and lidocaine in localized cutaneous leishmaniasis, 165 patients with different clinical forms of the disease were selected, from the Dermatology Services of the Central Hospital “Antonio María Pineda ”From Barquisimeto and the University Hospital of Maracaibo. Complete healing of the lesions was observed in 100% (128 of 128) of the patients treated with the Glucantime and lidocaine mixture, in 71.4% (20 of 28) of those treated only with Glucantime and only 11.1% (1 of 9) of those who received lidocaine alone. In 65.6% 4 of the cases healing occurred with 3 to 10 infiltrations and in 34.4% 11 to 18 doses were necessary. Standardization of the management and registration of leishmaniasis is suggested and treatment of localized forms with perilesional infiltrations of Glucantime plus lidocaine is recommended.

Published
2000-05-24
How to Cite
1.
Torres RA, Vargas de Caminos N. PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS. Kasmera [Internet]. 2000May24 [cited 2024Nov.23];28(2). Available from: https://produccioncientificaluz.org/index.php/kasmera/article/view/4668
Issue
Vol. 28 No. 2 (2000)
Section
Original Articles

Copyright (c) 2000 Reyes Alirio Torres, Nieves Vargas de Caminos

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.

The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.

Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.